1. Home
  2. Stocks
  3. Sotac Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Sotac Pharmaceuticals Ltd Share Price

    Small Cap
    ₹150.15
    + 7.15 (5%)
    15 September, 2024 18:29 BSE: NSE: SOTAC ISIN: INE0O2D01012

    Start SIP in Sotac Pharmaceuticals Ltd

    Start SIP

    Sotac Pharmaceuticals Ltd Performance

    Day Range

    • Low 150
    • High 150
    ₹ 150

    52 Week Range

    • Low 87
    • High 203
    ₹ 150
    • Open Price150
    • Previous Close143
    • Volume1200

    Sotac Pharmaceuticals Ltd Chart

    • Over 1 Month -7.03%
    • Over 3 Month + 27.25%
    • Over 6 Month + 22.97%
    • Over 1 Year + 25.12%

    Sotac Pharmaceuticals Ltd Key Statistics

    P/E Ratio 34.9
    PEG Ratio
    Market Cap Cr
    Price to Book Ratio 3.4
    EPS 5.2
    Dividend 0
    Relative Strength Index 49.07
    Money Flow Index 69.42
    MACD Signal 0.06
    Average True Range 6.67

    Sotac Pharmaceuticals Ltd Investment Rating

    • Master Rating:

    • Sotac Pharmaceuticals Ltd has an operating revenue of Rs. 104.11 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 15% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Sotac Pharmaceuticals Ltd Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 131618141913
    Operating Expenses Qtr Cr 111415121711
    Operating Profit Qtr Cr 223322
    Depreciation Qtr Cr 111100
    Interest Qtr Cr 000000
    Tax Qtr Cr 001001
    Net Profit Qtr Cr 111211
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 6858
    Operating Expenses Annual Cr 5750
    Operating Profit Annual in Cr 108
    Depreciation Cr 32
    Interest Annual Cr 11
    Tax Annual Cr 21
    Net Profit Annual Cr 64
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -209
    Cash from Investing Activity Annual Cr -13-11
    Cash from Financing Annual Activity Cr 2312
    Net Cash Flow Annual Cr -910
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 4812
    Fixed Assets Annual Cr 1814
    Total Non Current Assets Annual Cr 2918
    Total Current Assets Annual Cr 4737
    Total Assets Annual Cr 7655
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 4414
    ROE Annual % 1239
    ROCE Annual % 1725
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1715
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 252626272518
    Operating Expenses Qtr Cr 232523252316
    Operating Profit Qtr Cr 213222
    Depreciation Qtr Cr 111111
    Interest Qtr Cr 001001
    Tax Qtr Cr 0-11010
    Net Profit Qtr Cr 121111
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 10478
    Operating Expenses Annual Cr 9570
    Operating Profit Annual in Cr 97
    Depreciation Cr 32
    Interest Annual Cr 22
    Tax Annual Cr 02
    Net Profit Annual Cr 42
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -168
    Cash from Investing Activity Annual Cr -20-12
    Cash from Financing Annual Activity Cr 3013
    Net Cash Flow Annual Cr -610
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 4510
    Fixed Assets Annual Cr 3924
    Total Non Current Assets Annual Cr 4527
    Total Current Assets Annual Cr 6147
    Total Assets Annual Cr 10574
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 4513
    ROE Annual % 923
    ROCE Annual % 1019
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 910
    Invest in Sotac Pharmaceuticals Ltd

    Sotac Pharmaceuticals Ltd Technicals

    EMA & SMA

    Current Price
    ₹150.15
    + 7.15 (5%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹151.65
    • 50 Day
    • ₹147.99
    • 100 Day
    • ₹140.87
    • 200 Day
    • ₹133.74
    • 20 Day
    • ₹151.54
    • 50 Day
    • ₹148.10
    • 100 Day
    • ₹137.66
    • 200 Day
    • ₹129.66

    Sotac Pharmaceuticals Ltd Resistance and Support

    PIVOT
    ₹150.15
    Resistance
    First Resistance 150.15
    Second Resistance 150.15
    Third Resistance 150.15
    RSI 49.07
    MFI 69.42
    MACD Single Line 0.06
    MACD -1.06
    Support
    First Support 150.15
    Second Support 150.15
    Third Supoort 150.15

    Sotac Pharmaceuticals Ltd Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,200 120,000 100
    Week 1,200 120,000 100
    1 Month
    6 Month 6,232 542,892 87.11

    Sotac Pharmaceuticals Ltd Result Highlights

    Sotac Pharmaceuticals Ltd Synopsis

    NSE-Medical-Biomed/Biotech

    Sotac Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 57.98 Cr. and Equity Capital is Rs. 8.05 Cr. for the Year ended 31/03/2023. Sotac Pharmaceuticals Ltd is a Public Limited Listed company incorporated on 18/12/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ2015PLC085451 and registration number is 085451.
    Market Cap 166
    Sales 61
    Shares in Float 0.30
    No of funds 3
    Yield
    Book Value 3.44
    U/D Vol ratio 2.2
    LTDebt / Equity 9
    Alpha 0.09
    Beta 1.14

    Sotac Pharmaceuticals Ltd Shareholding Pattern

    Owner NameMar-24Sep-23
    Promoters 72.85%72.85%
    Foreign Portfolio Investors 8.99%8.52%
    Individual Investors 5.82%5.32%
    Others 12.34%13.31%

    Sotac Pharmaceuticals Ltd Management

    Name Designation
    Mr. Sharadkumar Dashrathbhai Patel Chairman & Managing Director
    Mr. Dineshkumar Babulal Gelot Whole Time Director
    Mr. Vishalkumar Devrajbhai Patel Executive Director
    Mr. Chetankumar Bachubhai Patel Executive Director
    Ms. Nidhiben Patel Ind. Non-Executive Director
    Ms. Hetal Umangbhai Shah Ind. Non-Executive Director
    Ms. Heena Viral Patel Ind. Non-Executive Director

    Sotac Pharmaceuticals Ltd Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Sotac Pharmaceuticals Ltd Corporate Action

    Date Purpose Remarks
    2024-08-13 Quarterly Results
    2024-05-17 Audited Results & Others To consider other business matters
    2023-11-06 Quarterly Results
    2023-05-29 Audited Results

    Sotac Pharmaceuticals Ltd MF Shareholding

    Name Amount(cr)

    Sotac Pharmaceuticals Ltd FAQs

    What is Share Price of Sotac Pharmaceuticals Ltd ?

    Sotac Pharmaceuticals Ltd share price is ₹150 As on 15 September, 2024 | 18:15

    What is the Market Cap of Sotac Pharmaceuticals Ltd ?

    The Market Cap of Sotac Pharmaceuticals Ltd is ₹165.9 Cr As on 15 September, 2024 | 18:15

    What is the P/E ratio of Sotac Pharmaceuticals Ltd ?

    The P/E ratio of Sotac Pharmaceuticals Ltd is 34.9 As on 15 September, 2024 | 18:15

    What is the PB ratio of Sotac Pharmaceuticals Ltd ?

    The PB ratio of Sotac Pharmaceuticals Ltd is 3.4 As on 15 September, 2024 | 18:15

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.